Fries C Anton, Villamaria Carole Y, Spencer Jerry R, Rickard Rory F, Gorantla Vijay S, Davis Michael R
Fort Sam Houston and San Antonio, Texas; Birmingham, United Kingdom; and Pittsburgh, Pa.
From the United States Army Institute of Surgical Research; the Royal Centre for Defence Medicine, ICT Centre; the Department of Surgery, University of Texas Health Science Center at San Antonio; 59MDW/Science and Technology, Joint Base San Antonio; and the University of Pittsburgh Medical Center.
Plast Reconstr Surg. 2016 Sep;138(3):461e-471e. doi: 10.1097/PRS.0000000000002451.
The restoration of complex tissue deficits with vascularized composite allotransplantation is a paradigm shift in reconstructive surgery. Clinical adoption of vascularized composite allotransplantation is limited by the need for systemic immunosuppression, with associated morbidity and mortality. Small-animal models lack the biological fidelity and preclinical relevance to enable translation of immunologic insights to humans. Large-animal models have been described; however, limitations persist, including the inability of heterotopic models to evaluate functional nerve regeneration, and the sensitivity of primates to toxicity of immunosuppressive drugs. The authors' novel orthotopic porcine limb transplant model has broad applicability and translational relevance to both immunologic and functional outcomes after vascularized composite allotransplantation.
Recipients underwent amputation at a level corresponding to the mid forearm. Replantation or transplantation of grafts was performed by plate fixation of the radio-ulna, microsurgical repair of brachial artery and median nerve, and extensor and flexor tendon repairs. Viability of replants was monitored clinically and radiologically. Transplants were monitored for clinicopathologic signs of rejection. Animals mobilized freely postoperatively.
Replantations remained viable until the endpoint of 14 days. Transplants developed Banff grade 4 acute rejection by postoperative day 7. Doppler sonography and angiography confirmed vascular patency. Serial biopsy specimens of skin and histopathology of replants at endpoint confirmed tissue viability and bone healing.
An orthotopic load-bearing porcine forelimb vascularized composite allotransplantation model was successfully established. Technical, procedural, and logistic considerations were optimized to allow model use for immunologic, bone healing, functional nerve regeneration, and other translational studies.
采用血管化复合组织异体移植修复复杂组织缺损是重建外科领域的一次范式转变。血管化复合组织异体移植的临床应用受到全身免疫抑制需求的限制,以及相关的发病率和死亡率。小动物模型缺乏生物学真实性和临床前相关性,无法将免疫学见解转化应用于人类。已有大型动物模型的描述;然而,局限性依然存在,包括异位模型无法评估功能性神经再生,以及灵长类动物对免疫抑制药物毒性的敏感性。作者新颖的原位猪肢体移植模型对于血管化复合组织异体移植后的免疫和功能结果具有广泛的适用性和转化相关性。
受体在前臂中部相应水平接受截肢手术。通过尺桡骨钢板固定、肱动脉和正中神经显微外科修复以及伸肌腱和屈肌腱修复进行移植物的再植或移植。临床和影像学监测再植肢体的存活情况。监测移植肢体的排斥反应临床病理体征。术后动物自由活动。
再植肢体直至14天的观察终点均保持存活。移植肢体在术后第7天出现班夫4级急性排斥反应。多普勒超声和血管造影证实血管通畅。终点时再植肢体的皮肤系列活检标本和组织病理学检查证实组织存活和骨愈合。
成功建立了原位承重猪前肢血管化复合组织异体移植模型。对技术、操作和后勤方面的考虑进行了优化,以使该模型可用于免疫、骨愈合、功能性神经再生及其他转化研究。